Hurst, CD and Knowles, MA (2014) Molecular subtyping of invasive bladder cancer: time to divide and rule? Cancer Cell, 25 (2). 135 - 136. ISSN 1535-6108
Abstract
Therapeutic decisions for muscle-invasive bladder cancer (MIBC) are largely based on histopathologic characteristics. In this issue of Cancer Cell, Choi and colleagues report three molecular subtypes of MIBC with the potential to guide prognosis, patient stratification, and treatment.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2014 Elsevier Inc. All rights reserved. This is an author produced version of a paper published in Cancer Cell. Uploaded in accordance with the publisher's self-archiving policy. |
Keywords: | Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Drug Resistance, Neoplasm; Female; Humans; Male; Muscle Neoplasms; Mutation; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Oncology (Leeds) The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Section of Experimental Oncology (Leeds) |
Depositing User: | Symplectic Publications |
Date Deposited: | 12 Aug 2015 11:32 |
Last Modified: | 24 Jan 2018 01:21 |
Published Version: | http://dx.doi.org/10.1016/j.ccr.2014.01.026 |
Status: | Published |
Publisher: | Cell Press |
Identification Number: | 10.1016/j.ccr.2014.01.026 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:86547 |